Zusammenfassung
Die ausgeprägte Motilität des menschlichen Magens wird durch neurale Prozesse koordiniert und bewirkt die kontinuierliche Durchmischung der Speise. Magenentleerungsstörungen werden vor allem bei mechanischen Hindernissen und bei der diabetischen Gastroparese gefunden. Die Abgabe von Sekret in das Duodenum ist das Ergebnis einer koordinierten Aktivität von Antrum und Duodenum; eine Störung dieser Aktivität kann zum duodenogastralen Reflux und zur Schädigung der Magenschleimhaut, v. a. durch die Exposition mit Gallensäuren führen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allen A, Flemstrom G, Garner A, Kivilaakso E (1993) Gastroduodenal mucosal protection. Physiol Rev 73:823
Andersson K, Chen D, Mattsson H, Sundler F, Hakanson R (1998) Physiological significance of ECL-cell histamine. Yale J Biol Med 71:183
Berglindh T, Helander HF, Obrink KJ (1976) Effects of secretagogues on oxygen consumption, aminopyrine accumulation and morphology in isolated gastric glands. Acta Physiol Scand 97:401
Black JW, Duncan WA, Durant CJ, Ganellin CR, Parsons EM (1972) Definition and antagonism of histamine H 2 -receptors. Nature 236:385
Byrne JP, Attwood SE (1999) Duodenogastric reflux and cancer. Hepatogastroenterology 46:74
Chen D, Zhao CM, Andersson K, Meister B, Panula P, Hakanson R (1998) ECL cell morphology. Yale J Biol Med 71:217
Creutzfeldt W, Lamberts R (1992) Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth. Digestion 51 [Suppl 1]:76–81
Cuomo R, Koek G, Sifrim D, Janssens J, Tack J (2000) Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 45:2463–2469
Davenport HW (1967) Salicylate damage to the gastric mucosal barrier. N Engl J Med 276:1307
DiBona DR, Ito S, Berglindh T, Sachs G (1979) Cellular site of gastric acid secretion. Proc Natl Acad Sci USA 76:6689
Dowall JE, Willis P, Prescott R, Lamonby S, Lynch DA (2000) Cell proliferation in type C gastritis affecting the intact stomach. J Clin Pathol 53:784–787
Fein M, Fuchs KH, Stopper H, Diem S, Herderich M (2000) Duodenogastric reflux and foregut carcinogenesis: analysis of duodenal juice in a rodent model of cancer. Carcinogenesis 21:2079–2084
Feldman M, Burton ME (1990) Histamine-2-receptor antagonists. Standard therapy for acid-peptic diseases (2). N Engl J Med 323:1749
Fellenius E, Berglindh T, Sachs G et al. (1981) Substituted ben-zimidazoles inhibit gastric acid secretion by blocking (H+- + K+-)ATPase. Nature 290:159
Forssmann WG, Lichtenberger LM, Helmstaedter V, Ito S (1979) Studies of isolated and enriched rat antral mucosa gastrin cells. Cell Tissue Res 200:163
Gantz I, Schaffer M, DelValle J et al. (1991) Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci USA 88:429
Hakanson R, Chen D, Tielemans Y et al. (1994) ECL cells: biology and pathobiology. Digestion 55 [Suppl 3]:38–45
Hakanson R, Owman C, Sporrong B, Sundler F (1971) Electron microscopic identification of the histamine-storing argyro-phil (enterochromaffin-like) cells in the rat stomach. Z. Zell-forsch. Mikrosk Anat 122:460
Helander HF (1981) The cells of the gastric mucosa. Int Rev Cy-tol 70:217–289
Hersey SJ, Sachs G. Gastric acid secretion. Physiol Rev 75:155
Hinder RA, Kelly KA (1977) Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg 133:29
Hunt JN, Cash R, Newland P (1975) Energy density of food, gastric emptying, and obesity. Lancet 11:905
Kajimura M, Reuben MA, Sachs G (1992) The muscarinic receptor gene expressed in rabbit parietal cells is the m3 subtype. Gastroenterology 103:870
Kelly KA, Code CF (1977) Duodenal-gastric reflux and slowed gastric emptying by electrical pacing of the canine duodenal pacesetter potential. Gastroenterology 72:429
Kovacs TO, Walsh JH, Maxwell V, Wong HC, Azuma T, Katt E (1989) Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization. Gastroenterology 97:1406
Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E (1993) Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:1356
Lichtenberger LM (1982) Importance of food in the regulation of gastrin release and formation. Am J Physiol 243:G429
Lichtenberger LM, Dial EJ, Romero JJ, Lechago J, Jarboe LA, Wolfe MM (1995) Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat. Gastroenterology 108:320
Lichtenberger LM, Nelson AA, Graziani LA (1986) Amine trapping: physical explanation for the inhibitory effect of gastric acidity on the postprandial release of gastrin. Studies on rats and dogs. Gastroenterology 90:1223
Longstreth GF, Go VL, Malagelada JR (1977) Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists active duodenal ulcer. Gastroenterology 72: 9
Manifold DK, Anggiansah A, Marshall RE, Owen WJ (2001) Reproducibility and intragastric variation of duodenogastric reflux using ambulatory gastric bilirubin monitoring. Dig Dis Sci 46:78–85
Marshall RE, Anggiansah A, Owen WA, Manifold DK, Owen WJ (2001) The extent of duodenogastric reflux in gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 13:5–10
Maton PN (1991) Omeprazole. N Engl J Med 324:965
Menges M, Muller M, Zeitz M (2001) Increased acid and bile reflux in Barrett’s esophagus compared to reflux esophagi-tis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 96:331–337
Muller MJ, Defize J, Hunt RH (1990) Control of pepsinogen synthesis and secretion. Gastroenterol Clin North Am 19:27
Nakamura M, Haruma K, Kamada T et al. (2001) Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 53:53–59
Passaro U, Vasapollo L, Carnevale L et al. (2001) Duodenogastric reflux in gallbladder stones and after laparotomic cholecystectomy. Minerva. Chirurg 56:139–146
Prinz C, Scott DR, Hurwitz D, Helander HF, Sachs G (1994) Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. Am J Physiol 267:G663
Prinz C, Zanner R, Gerhard M et al. (1999) The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol 277:C845
Sachs G, Chang HH, Rabon E, Schackman R, Lewin M, Saccomani G (1976) A non-electrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem 251:7690
Sachs G, Zeng N, Prinz C (1997) Physiology of isolated gastric endocrine cells. Annu Rev Physiol 59:243–256
Schepp W, Prinz C, Hakanson R, Schusdziarra V, Classen M (1990) Bombesin-like peptides stimulate gastrin release from isolated rat G-cells. Regul Pept 28:241
Schepp W, Ruoff HJ, Dein HJ, Miederer S (1986) Effects of glucagon and histamine on human parietal cells. Agents Actions 18:214
Schmidtler J, Dehne K, Offermanns S, Rosenthal W, Classen M, Schepp W (1994) Stimulation of rat parietal cell function by histamine and GLP-l-(7–36) amide is mediated by Gs alpha. Am J Physiol 266:G775
Schrager J, Oates MD (1968) The carbohydrate components of hy-drolysates of gastric secretion and extracts from mucous glands of the gastric body mucosa and antrum. Biochem J 106:523
Scott DR, Hersey SJ, Prinz C, Sachs G (1993) Actions of antiulcer drugs. Science 262:1453
Siewert R, Blum AL (1977) Introduction: gastrointestinal motility. Z Gastroenterol 15:157
Soil AH (1978) Effects of the H2-antagonists on histamine action and interaction with gastrin in isolated parietal cells. Gastroenterology 74:355
Soll AH, Grossman MI (1978) Cellular mechanisms in acid secretion. Annu Rev Med 29:495–507
Stein HJ, Kauer WK, Feussner H, Siewert JR (1999) Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology 46:66
Stubbs DF, Hunt JN (1975) A relation between the energy of food and gastric emptying in men with duodenal ulcer. Gut 16:693
Thitiphuree S, Talley NJ (2000) Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract 54:537–541
Tripathi BK (1999) Diabetic gastroparesis. J Assoc Physicians India 47:1176
Vaezi MF, Richter JE (2000) Duodenogastro-oesophageal reflux. Baillieres. Best Pract Res Clin Gastroenterol 14:719–729
Wang TC, Dangler CA, Chen D et al. (2000) Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118:36–47
Wang TC, Dockray GJ (1999) Lessons from genetically engineered animal models. I. Physiological studies with gastrin in transgenic mice. Am J Physiol 277:G6
Wank SA (1998) G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. Am J Physiol 274:G607
Wolosin JM, Forte JG (1981) Changes in the membrane environment of the (K+- + H+-)ATPase following stimulation of the gastric oxyntic cell. J Biol Chem 256:3149
Anderson J, Gonzalez J (2000) H. pylori infection. Review of the guideline for diagnosis and treatment. Geriatrics 55:44
Anonymous (1993) An international association between Helicobacter pylori infection and gastric cancer. The EURO-GAST Study Group. Lancet 341:1359
Asaka M, Kimura T, Kato M et al. (1994) Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73:2691
Blum AL, Talley NJ, O’Morain C et al. (1998) Lack of effect of treating Helicobacter pylori infection in patients with no-nulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 339:1875
Borchard F (2001) Chemical-reactive gastritis. Pathologe 22:44
Censini S, Lange C, Xiang Z et al. (1996) Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648
Coffey RJ, Romano M, Goldenring J (1995) Roles for transforming growth factor-alpha in the stomach. J Clin Gastroenterol 21 :S36
Cohen MC, Cueto RE, Balcarce N, Donatone J, Drut R (2000) Assessment of the Sydney system in helicobacter pyloriassociated gastritis in children. Acta Gastroenterol Latinoam 30:35
Cohen ME, Taylor MB (2000) Treatment of phlegmonous gastritis. J Clin Gastroenterol 30:100
Correa P (1995) The role of antioxidants in gastric carcinogenesis. Crit Rev Food Sci Nutr 35:59
Correa P, Chen VW (1994) Gastric cancer. Cancer Surv 19/20:55–76
Correa P, Miller MJ (1994) Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 54:151
Correa P, Shiao YH (1994) Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 54:1941
Correa P, Malcom G, Schmidt B et al. (1998) Review article: Antioxidant micronutrients and gastric cancer. Aliment Pharmacol Ther 12 (Suppl l):73–82
Crabtree JE (1996) Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10:29
D’Elios MM, Bergman MP, Azzurri A et al. (2001) H(+)-K(+)-ATPase (proton pump) is the target autoantigen of Thl-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 120:377
Ectors N, Geboes K, Wynants P, Desmet V (1992) Granulomatous gastritis and Whipple’s disease. Am J. Gastroenterol 87:509
El-Omar EM (2001) The importance of interleukin lbeta in Helicobacter pylori associated disease. Gut 48:743
El-Omar EM, Carrington M, Chow WH et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398
Fontham ET, Ruiz B, Perez A, Hunter F, Correa P (1995) Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 90:1094
Forman D (1991) Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst 83:1702
Forman D (1991) The etiology of gastric cancer. IARC Sci Pubi 105:22–32
Forman D (1998) Helicobacter pylori infection and cancer. Br Med Bull 54:71
Forman D, Newell DG, Fullerton F et al. (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302:1302
Forman D, Webb P, Parsonnet J (1994) H pylori and gastric cancer. Lancet 343:243
Gumaste VV, Janowitz HD, Waye JD (1989) Granulomatous gastritis: a case report and review of the literature. Am J Gastroenterol 84:1315
Heatley RV (1998) The Maastricht Consensus Report. Dual publication. Gut 42:595
Hentschel E (2000) Treatment of Helicobacter pylori infections. Acta Med Austriaca 27:104
Kokkola A, Haapiainen R, Laxen F et al. (1996) Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. J Clin Pathol 49:979
Lichtenstein JE (1993) Inflammatory conditions of the stomach and duodenum. Radiol Clin North Am 31:1315
McColl K, Murray L, El-Omar E et al. (1998) Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 339:1869
McNamara D, O’Morain C (2000) Consensus guidelines: agreement and debate surrounding the optimal management of Helicobacter pylori infection. Can J Gastroenterol 14:511
Meining A, Bayerdorffer E, Muller P et al. (1998) Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 432:311
Muller H, Rappel S, Volkholz H, Stolte M (2001) Lymphocytic gastritis — a rare disorder of the gastric mucosa. Pathologe 22:56
Nielsen JA, Thaysen EH, Olesen H, Nielsen AR (1972) Fundal gastritis after Billroth-II-type resection in patients with duodenal ulcer. Scand J Gastroenterol 7:337
Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez Gl, Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132
Oberhuber G, Haidenthaler A (2000) Histopathology of Helicobacter pylori infections. Acta Med Austriaca 27:100
Oberhuber G, Wuendisch T, Rappel S, Stolte M (1998) Significant improvement of atrophy after eradication therapy in atrophic body gastritis. Pathol Res Pract 194:609
Parsonnet J, Friedman GD, Vandersteen DP et al. (1991a) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127
Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y (1991b) Helicobacter pylori infection in intestinal-and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640
Prinz C, Schoniger M, Rad R et al. (2001) Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 61:1903
Radhi J, Kamouna M, Nyssen (1999) Phlegmonous gastritis following coronary bypass surgery. Can J Gastroenterol 13:837
Sachs M, Encke A (1993) Menetrier disease — a rare disease of the stomach. Zentralbl Chir 118:160
Sipponen P (1989) Atrophic gastritis as a premalignant condition. Ann Med 21:287
Sipponen P, Kimura K (1994) Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 6:S79
Sipponen P, Hyvarinen H, Seppala K, Blaser MJ (1998) Pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther 12:61
Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M (1985) Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35:173
Sipponen P, Kekki M, Siurala M (1991) The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 6:244
Sood BP, Kalra N, Suri S (2000) CT features of acute phlegmonous gastritis. Clin Imaging 24:287
Stolte M, Meining A (1998) Helicobacter pylori and gastric cancer. Oncologist 3:124
Stolte M, Meier E, Meining A (1998) Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male. Z Gastroenterol 36:641
Talley NJ, Vakil N, Ballard ED, Fennerty MB (1999) Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 341:1106
Treem WR, Ragsdale BD (1988) Crohn’s disease of the esophagus: a case report and review of the literature. J Pediatr Gastroenterol Nutr 7:451
Tytgat G, Malfertheiner P (2000) Practice and principle: the influence of current research on our management of acid-related disorders. Summary: key messages. Eur J Gastroenterol Hepatol 1(12):S21
Wagner S, Beil W, Westermann J et al. (1997) Regulation of gastric epithelial cell growth by Helicobacter pylori: offden-ce for a major role of apoptosis. Gastroenterology 113:1836
Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642
Xia HH, Talley NJ (1999) Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs 58:785
Zuckerman MJ, al-Samman M, Boman DA (1994) Granulomatous gastroenteritis. Case report with comparison to idiopathic isolated granulomatous gastritis. Dig Dis Sci 39:1649
Akiba Y, Kaunitz JD (1999) Regulation of intracellular pH and blood flow in rat duodenal epithelium in vivo. Am J. Physiol 276:G293
Allen A, Flemstrom G, Garner A, Kivilaakso E (1993) Gastro-duodenal mucosal protection. Physiol Rev 73:823
Anand BS, Romero JJ, Sanduja SK, Lichtenberger LM (1999) Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol 94:1818
Bombardier C, Laine L, Reicin A et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520
Borchard F (2001) Chemical-reactive gastritis. Pathologe 22:44
Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283–297
Byrne JP, Attwood SE (1999) Duodenogastric reflux and cancer. Hepatogastroenterology 46:74
Caspary WF, Arnold R, Bayerdorffer E et al. (1996) Diagnosis and therapy of helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 34:392
Cook DJ. Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis. Scand J Gastroenterol Suppl 210:48–52
Cook DJ, Fuller HD, Guyatt GH et al. (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330:377
Cook DJ, Reeve BK, Guyatt GH et al. (1996) Stress ulcer prophylaxis in critically ill patients. Resolving discordant metaanalyses. JAMA 275:308
Cryer B, Feldman M (1998) Cyclooxygenase-1 and cyclooxyge-nase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 104:413
Cryer B, Feldman M (1999) Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 17:17
Davenport HW(1967) Ethanol damage to canine oxyntic glandular mucosa. Proc Soc Exp Biol Med 126:657
Davenport HW (1967) Salicylate damage to the gastric mucosal barrier. N Engl J Med 276:1307
Devlin JW, Ben-Menachem T, Ulep SK, Peters MJ, Fogel RP, Zarowitz BJ (1998) Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endo-scopically proven stress ulceration. Ann Pharmacother 32:869
Dowall JE, Willis P, Prescott R, Lamonby S, Lynch DA (2000) Cell proliferation in type C gastritis affecting the intact stomach. J Clin Pathol 53:784
Fein M, Fuchs KH, Stopper H, Diem S, Herderich M (2000) Duodenogastric reflux and foregut carcinogenesis: analysis of duodenal juice in a rodent model of cancer. Carcinogenesis 21:2079
Fontham ET, Ruiz B, Perez A, Hunter F, Correa P (1995) Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 90:1094
Gabriel SE, Jaakkimainen L, Bombardier C (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787
Hamlet A, Olbe L (1996) The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 111:391
Hawkey CJ, Karrasch JA, Szczepanski L et al. (1998) Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 338:727
Hudson N, Taha AS, Russell RI et al. (1997) Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology 112:1817
Lasky MR, Metzler MH, Phillips JO (1998) A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 44:527
Lau JY, Sung J J, Lee KK et al. (2000) Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343:310–316
Levy MJ, Seelig CB, Robinson NJ, Ranney JE (1997) Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 42:1255
Lichtenberger LM, Dial EJ, Romero JJ, Lechago J, Jarboe LA, Wolfe MM (1995) Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat. Gastroenterology 108:320
Maaroos HI, Kekki M, Sipponen P, Salupere V, Villako K (1991) Grade of helicobacter pylori colonisation, chronic gastritis and relative risks of contracting high gastric ulcers: a seven-year follow-up. Scand J Gastroenterol Suppl 186:65–72
Miranda M, Defllippi C, Valenzuela JE (1985) Abnormalities of interdigestive motility complex and increased duodenoga-stric reflux in gastric ulcer patients. Dig Dis Sci 30:16
Mobley HL (1997) Helicobacter pylori factors associated with disease development. Gastroenterology 113:S21
Nakamura M, Haruma K, Kamada T et al. (2001) Duodenoga-stric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 53:53–59
Nakayama J, Yeh JC, Misra AK, Ito S, Katsuyama T, Fukuda M (1999) Expression cloning of a human alpha1, 4-N-acetyl-glucosaminyltransferase that forms GlcNAcal-4GalßR, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc Natl Acad Sci USA 96:8991
Pruitt BAJ, Foley FD, Moncrief JA (1970) Curling’s ulcer: a clinical-pathology study of 323 cases. Ann Surg 172:523
Rhodes J, Barnardo DE, Phillips SF, Rovelstad RA, Hofmann AF (1969) Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 57:241
Rosen HR, Vlahakes GJ, Rattner DW (1992) Fulminant peptic ulcer disease in cardiac surgical patients: pathogenesis, prevention, and management. Crit Care Med 20:354
Rosin D, Rosenthal RJ, Bonner G, Grove MK, Sesto ME (2001) Gastric MALT lymphoma in a Helicobacter pylori-negative patient: a case report and review of the literature. J Am Coll Surg 192:652
Schilling D, Haisch G, Sloot N, Jakobs R, Saggau W, Riemann JF (2000) Low seroprevalence of Helicobacter pylori infection in patients with stress ulcer bleeding — a prospective evaluation of patients on a cardiosurgical intensive care unit. Intensive Care Med 26:1832–1836
Shirin H, Moss SF (1998) Helicobacter pylori induced apopto-sis. Gut 43:592
Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K (1992) Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 45:319
Sipponen P (1992) Helicobacter pylori, chronic gastritis and peptic ulcer. Mater Med Pol 24:166
Soil AH (1990) Pathogenesis of peptic ulcer and implications for therapy. N Engl J Med 322:909
Stein HJ, Kauer WK, Feussner H, Siewert JR (1999) Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology 46:66
Stolte M, Seitter V, Muller H (2001) Improvement in the quality of the endoscopic/biotpic diagnosis of gastric ulcers between 1990 and 1997, an analysis of 1658 patients. Z Gastroenterol 39:349
Taha AS, Hudson N, Hawkey CJ et al. (1996) Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 334:1435
Takahashi S, Takeuchi K, Okabe S (1999) EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells. Biochem.Pharmacol 58:1997
Takakura K, Harada J, Mizogami M, Goto Y (1994) Prophylactic effects of pirenzepine (Ml-blocker) on intraoperative stress ulcer: comparison with an H2-blocker. Anesth Analg 78:84
Thomason MH, Payseur ES, Hakenewerth AM et al. (1996) Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma 41:503
Tryba M, Cook D (1997) Current guidelines on stress ulcer prophylaxis. Drugs 54:581
Tryba M (1987) Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids. Am J Med 83:117
Vaezi MF, Richter JE (2000) Duodenogastro-oesophageal reflux. Baillieres. Best Pract Res Clin Gastroenterol 14:719
Walt RP (1992) Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N Engl J Med 327:1575
Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888
Wormsley KG, Grossman MI (1965) Maximal histalog test in control subjects and patients with peptic ulcer. Gut 6:427
Yeomans ND, Tulassay Z, Juhasz L et al. (1998) A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 338:719
Zuckerman GR, Shuman R (1987) Therapeutic goals and treatment options for prevention of stress ulcer syndrome. Am J Med 83:29
Ablaßmeier B, Steinhilper U, Bandi WD, Ziehen T, Münster W, Föckersperger H (1994) 100 Jahre nach Billroth ... Laparoskopische distale Magenresektion (Billroth I und Billroth II). Chirurg 65:367–372
Arlt G, Schumpelick V, Klöppel G (1984) Das Ulcus-Risiko des Roux-Y-Magens. Langenbecks Arch Chir 362:43–52
Baehrlehner E, Lenschel E, Fischer R (1979) Die einreihige extramucose Adaptationsnaht (Naht auf Stoß) bei der Magenresektion nach Billroth I. Dtsch Gesundheitswesen 31:1466
Becker HD, Lehmann L, Löhlein D, Schumpelick V, Troidl H (1982) Selektiv-proximale Vagotomie mit Ulcusexzision oder Billroth-I-Resektion beim chronischen Ulcus ventricu-li. Chirurg 53:773–777
Borg J, Bergström S (1969) Spätergebnisse der Resektionsbehandlung nach Billroth-I und Billroth-II in der Ulcuschirur-gie. Bruns Beitr Klein Chir 217:481
Cooper G, Bell G (1982) Combined antrectomy and Roux-en-Y anastomosis in the surgical treatment of recurrent peptic ulceration. Br J Surg 69:646–650
Demartines N, Rothenbiihler JM, Chevalley JP, Harder F (1991) The single-layer continuous suture for gastric anastomosis World J Surg 1991;15:522–525
Duthie HL (1977) Surgery for peptic ulcer. World J Surg 1:29
Duthie HL, Kwong NK (1973) Vagotomy or gastrectomy for gastric ulcer. Br Med J IV:79–81
Emas S, Fenstroem M (1985) Prospective randomized trials of selective vagotomy with pyloroplasty and selective proximal vagotomy with and without pyloroplasty in the treatment of duodenal, pyloric and prepyloric ulcers. Am J Surg 149(2):236–243
Ernas S, Hammerberg C (1983) Prospective, randomized trial of selective proximal vagotomy with ulcer excision and partial gastrectomy with gastroduodenostomy in the treatment of corporeal gastric ulcer. Am J Surg 146:631–634
Exalto J (1910) Ulcus jejuni nach Gastroenterostomie. Mitt Grenzb Med 22:13–41
Goh P, Tekant Y, Isaac J, Kum CK, Ngoi SS (1992) The technique of laparoscopic Billroth II gastrectomy. Surg Laparosc En-dosc 3:258–260
Goh P, Alponat A, Mak K, Kum CK (1997) Early international results of laparoscopic gastrectomies. Surg Endosc 11:650–652
Haglund UH, Jansson RL, Lindhagen JGE, Lundell LR, Svartholm EG, Olbe LC (1990) Primary Roux-Y-gastrojejunostomy versus gastroduodenostomy after antrectomy and selective vagotomy. Am J Surg 159:546–549
Harkins HN (1969) Gastric resection Billroth I. In: Harkins HN, Nyhus LM (eds) Surgery of the stomach and duodenum, 2nd edn. Little Brown, Boston, p 491
Hölscher AH, Siewert JR (1984) Stellenwert der Billroth-II-Ma-genresektion mit Roux-Y-Anastomose bei der Refluxösophagitis. In: Bunte H, Grill W, Langhans P, Siewert JR (Hrsg) Die Roux-Schlinge. Indikationen, Techniken und Resultate. Edition Medizin, Weinheim Deerfield Beach Florida Basel, S 175–180
Hölscher AH, Klingele C, Bollschweiler E, Schröder W, Be-ckurts KTE, Siewert JR (1996) Postoperatives Rezidivulcus nach Magenresektion — Ergebnisse der chirurgischen Behandlung. Chirurg 67:814–820
Hölscher AH, Bumm R, Siewert JR (1990) Chirurgische Therapieprinzipien bei der Rezidivprophylaxe. In: Bauerfeind P, Blum AL (Hrsg) Ulkusalmanach 1+2. Springer, Berlin Heidelberg New York Tokyo, S 87–113
Hölscher AH, Siewert JR (1991) Operationsindikation und chirurgische Therapie des Ulcus ventriculi. Chir Gastroenterol 4:513–521
Hollender LF, Buhr F, van Petegen RP, Alexion D, Starlinger M (1978) Hat die Resektion nach Billroth I beim Magengeschwür an Bedeutung verloren? Zentralbl Chir 103:329
Horsburgh AG, Cox RA (1965) A comparison of Polya and Billroth gastrectomy. Gastroenterology 49:381
Johnston D (1975) Operative mortality and postoperative morbidity of highly selective vagotomy. Br J Surg 62:160
Junginger T, Stutzer H (1986) Lebenserwartung nach Magenresektion bei gastroduodenalem Ulkus. Dtsch Med Wo-chenschr III(12):447–452
Jordan PH (1996) Type I gastric ulcer treated by parietal cell vagotomy and mucosal ulcerectomy. J Am Coll Surg 182(5):388–393
Karlqvist PA, Anderberg B, Olaison G, Sjodahl R (1986) Early and late results after antrectomy, selective vagotomy and Roux-en-Y reconstruction for severe peptic ulcer disease. Acta Chir Scand 152:357–361
Kennedy T, Green R (1978) Roux-diversion for bile reflux following gastric surgery. Br J Surg 65:323–325
Kraft-Kinz J, Kronberger L (1977) Operationsbedingte Misserfolge bei der Magenresektion nach Billroth I. Zentralbl Chir 102:1194
Kraus M, Mendeloff G, Condon RE (1976) Prognosis of gastric ulcer. Ann Surg 184:471
Langhans P (1984) Die Roux-Schlinge in der Ulcuschirurgie. In: Bunte H, Grill W, Langhans P, Siewert JR (Hrsg) Die Roux-Schlinge. Indikationen, Techniken, Resultate, edition medizin, Weinheim Deerfìeld Beach Basel, S 151–167
Liavag I (1981) Reoperation because of early complications after gastroduodenal surgery. Tidsskr Nor Laegeforen 101: 1875–1877
Madsen P, Kronborg Q, Hansen OH, Pedersen T (1976) Billroth-I gastric resection versus truncal vagotomy and pyloroplasty in the treatment of gastric ulcer. Acta Chir Scand 142:151
McKeown KD (1970) A study of peptic ulcer. Br J Surg 57:131
Melström D, Rutgreen A (1982) Long-term effects after partial gastrectomy in elderly men. Scand J Gastroenterol 17:433
Menguy R, Chey W (1980) Experiences with the treatment of alkaline reflux gastritis. Surgery 88:482–487
Nielsen J, Amdrup E, Christiansen P (1973) Gastric ulcer II, Surgical treatment. Acta Chir Scand 139:460
Nielsen OV, Jorgensen SP, Pedersen G (1974) Roux-enY anastomosis in the treatment of chronic afferent loop syndrome. Acta Chir Scand 140:531–534
Ornsholt J, Amdrup E, Andersen D, Hostrup H (1983) Arhus County Vagotomy Trial: ulcer recurrence rate related to alterations in gastric acid secretion after selective gastric and parietal cell vagotomy. Scand J Gastroenterol 18(4):465–472
Ovaska JT, Ekfors TO, Luukkonen PE, Lempinen MJ (1988) Histological changes in the gastric stump mucosa and late clinical results after Billroth I, Billroth II and Roux-en-Y operations for peptic ulcer disease. Ann Chir Gynaecol 77(1):l–5
Pääkonen M, Alhava EM, Ankee S, Lahtinen J, Poikolainen E, Syrjamen K (1987) Roux-en-Y reconstruction compared with Billroth I in chronic pyloric or prepyloric ulcer. 32nd World Congress of Surgery. Sydney Sept. 20–26. Book of Abstracts, p 200
Pichlmayr R, Lehr L (1981) The treatment of recurrent ulcer after stomach resection with thoracic vagotomy. Chirurg 52(4):247–253
Petrat H, Schröder H, Jacob M, Petrat G (1991) Results of Billroth I and Billroth II stomach resection. Zentralbl Chir 116(6):369–373
Reid DA, Duthie HL, Bransom CJ, Johnson AG (1982) Late follow-up of highly selective vagotomy with excision of the ulcer compared with Billroth I gastrectomy for treatment of benign gastric ulcer. Br J Surg 69:605–607
Rieu PMNA, Joosten HJM, Jansen JBMJ, Lamers CBHW (1994) A comparative study of gastrectomy without vagotomy with either Roux-en-Y or Billroth II anastomosis in peptic ulcer. Hepato-Gastroenterol 41:294–297
Salzer G (1967) Indikationen zur Resektion nach Billroth I und Billroth II einschließlich des hochsitzenden Ulcus. Klin Med 22:13
Sapala JA, Ponker J (1973) Operative treatment of benign gastric ulcers. Am J Surg 125:19
Semb LS, Montclair T, Brunsgaard C (1973) Partial gastrectomy with gastro-duodenal anastomosis with or without truncal vagotomy in the treatment of peptic ulcer. Acta Hepato-gastroenterol 20:178
Siewert JR, Hölscher AH (1986) Billroth I gastrectomy. In: Nyhus Wastell C (ed) Surgery of the stomach and duodenum, 4th edn. Little Brown, Boston Toronto, pp 263–290
Shiraishi N, Adachi Y, Kitano S et al. (1999) Indication for and outcome of laparoscopy-assisted Billroth I gastrectomy. Br J Surg 86:541–544
Siedeck M, Lindeken KD, Birtel FJ, Rubinger M, Ebener J (1984) B II Roux-Y-Anastomose — Resektionsverfahren der Wahl bei der komplizierten Ulkuskrankheit? Langenbecks Arch Chir 362:61
Tanner N (1976) Personal observations and experiences in the diagnosis and management of ulcer diseases and disability that follow ulcer peptic operation. Surg Clin North Am 56:1349–1363
Thomas WEG, Thompson MH, Williamson RCN (1982) The long-term outcome of Billroth-I partial gastrectomy for benign gastric ulcer. Ann Surg 195:189
Walgenbach S, Junginger Th (1992) Ergebnisse der Magenresektion mit Gastrojejunostomie nach Roux wegen gastro-duodenaler Ulcera. Chirurg 63:511–515
Walters W, Lynn TE (1956) Results of 237 Billroth-I gastric resections for peptic ulcer: A 6–15 year follow-up. Ann Surg 144:464
Winkler R, Farthmann E, Eichfuß HP (1977) Die B-I Resektion in der Ulcuschirurgie. Langenbecks Arch Chir 343:123
Zornig C, Emmermann A, Blochle C, Jackie S (1998) Laparoscopic 2/3 resection of the stomach with intracorporal Roux-en-Y anastomosis. Chirurg 69:467–470
Bendtsen F, Rosenkilde-Gram B, Tage-Jensen U, Ovesen L, Rune SJ (1987) Duodenal bulb acidity in patients with duodenal ulcer. Gastroenterology 93:1263
Blair AJ, Richardson CT, Vasko M, Walsh JH, Feldman M (1986) Comparison of acid secretory responsiveness to gastrin heptadecapeptide and of gastrin heptadecapeptide pharmacokinetics in duodenal ulcer patients and normal subjects. J Clin Invest 78:779
Blaser MJ, Crabtree JE (1996) CagA and the outcome of Helicobacter pylori infection. Am J. Clin Pathol 106:565
Blaser MJ (1998) Helicobacter pylori and gastric diseases. BMJ 316:1507
Blaser MJ (1995) The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease. Aliment Pharmacol Ther 9 (Suppl l):27–30
Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283
Canducci F, Ojetti V, Pola P, Gasbarrini G, Gasbarrini A (2001) Rifabutin-based Helicobacter pylori eradication „rescue therapy“. Aliment Pharmacol Ther 15:143
Caspary WF, Arnold R, Bayerdorffer E et al. (1996) Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 34:392
Censini S, Lange C, Xiang Z et al. (1996) Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648
Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328
Cover TL, Blaser MJ (1996) Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 41:85–117
Feldman M, Richardson CT (1986) Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of Cimetidine and parietal cell vagotomy. Gastroenterology 90:540
Forrest JA, Finlayson ND, Shearman DJ (1974) Endoscopy in gastrointestinal bleeding. Lancet 2:394
Gillen D, El-Omar EM, Wirz AA, Ardili JE, McColl KE (1998) The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology 114:50
Graham DY (2000) Therapy of Helicobacter pylori: current status and issues. Gastroenterology 118:S2
Hamlet A, Olbe L (1996) The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 111:391
Hentschel E, Brandstatter G, Dragosics B et al. (1993) Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328:308
Herbrink P, van Doom LJ (2000) Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy. Eur J Clin Microbiol Infect Dis 19:164
Isenberg JI, Grossman MI, Maxwell V, Walsh JH (1975) Increased sensitivity to stimulation of acid secretion by penta-gastrin in duodenal ulcer. J Clin Invest 55:330
Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311
McNamara D, O’Morain C (2000) Consensus guidelines: agreement and debate surrounding the optimal management of Helicobacter pylori infection. Can J Gastroenterol 14:511
Mobley HL (1997) Helicobacter pylori factors associated with disease development. Gastroenterology 113:S21
Parsonnet J (1998) Helicobacter pylori. Infect Dis Clin North Am 12:185
Peek RMJ, Blaser MJ (1997) Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med 102:200
Perri F, Festa V, Clemente R et al. (2001) Randomized study of two „rescue“ therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol 96:58
Shirin H, Moss SF (1998) Helicobacter pylori induced apopto-sis. Gut 43:592
Sipponen P, Hyvarinen H, Seppala K, Blaser MJ (1998) Review article: Pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther 12 (Suppl 1): 61
Soll AH (1990) Pathogenesis of peptic ulcer and implications for therapy. N Engl J Med 322:909
Tytgat G, Malfertheiner P (2000) Practice and principle: the influence of current research on our management of acid-related disorders. Summary: key messages. Eur J Gastroenterol Hepatol 12:S21
Vaira D, Holton J, Menegatti M et al. (1998) Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group. Gut 43 (Suppl 1): S39
Vaira D, Miglioli M, Holton J, Mule P, Barbara L (1991) Screening for Helicobacter pylori. Lancet 338:1149
Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642
Weeks DL, Eskandari S, Scott DR, Sachs G (2000) A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 287: 482
Wormsley KG, Grossman MI (1965) Maximal histalog test in control subjects and patients with peptic ulcer. Gut 6:427
Cadière GB, Bruyns J, Himpens J, Van Alphen P, Verturyen M (1999) Laparoscopic highly selective vagotomy. Hepato-Gastroenterol 46:1500–1506
Casas AT, Gadacz TR (1996) Laparoscopic management of peptic ulcer disease. Laparosc Surg 76 (3):515
Croce E, Olmi S, Russo R, Azzola M, Matropasqua E, Golia M (1999) Laparoscopic treatment of peptic ulcers. A review after 6 years experience with Hill-Barkers procedure. Hepato-Gastroenterol 46:924–929
Dallemagne B, Weetes JM, Jehaes C, Markiewicz S, Lombard R (1994) Laparoscopic highly selective vagotomy. Br J Surg 81:554–556
Donahue PE (2000) Parietal cell vagotomy versus vagotomy-antrectomy: Ulcer surgery in the modern era. World J Surg 24:264–269
Dragstedt LR (1945) Vagotomy for gastroduodenal ulcer. Ann Surg 122:973–989
Dubois F (1994) Vagotomies — laparoscopic or thoracoscopic approach. End Surg 2:100–104
Ernas S, Grupcev G, Eriksson B (1993) Six-year results of a prospective, randomized trial of selective proximal vagotomy with and without pyloroplasty in the treatment of duodenal, pyloric, and prepyloric ulcers. Ann Surg 217:16–14
Gillispie G, Elder JB, Smith IS, Kennedy F (1970) An analysis of spontaneous acid secretion and its relation to the insulin response in normal and duodenal ulcer subjects. Br J Surg 57:855
Gómez-Ferrer F, Balique JG, Azagra S et al. (1996) Laparoscopic surgery for duodenal ulcer: first results of a multicentre study applying a personal procedure. Br J Surg 83:547–550
Gorey TF, Lennon F, Heffernan SJ (1984) Highly selective vagotomy in duodenal ulceration and its complications. A 12-year review. Ann Surg 200:181–184
Griffiths CA, Harkins HN (1957) Partial gastric vagotomy: An experimental study. Gastroenterology 32:97–101
Helms B, Czarnetzki HD, Scharlau U (1994) Laparoscopic proximal gastric vagotomy — neuralgic points of technique. En-dosc Surg Allied Technol 2:109–112
Hildebrandt J, Herrmann U (1992) Selective proximal vagotomy with and without pyloroplasty in uncomplicated chronic duodenal ulcer. Results of a randomized clinical study 5 and 10 years following surgery. Zentralbl Chir 117 (l):36–40
Hölscher AH, Bollschweiler E, Seebauer L. Alcock ATR, Sie-wert JR (1989) Experience with long-term intragastric pH monitoring as a test after proximal gastric vagotomy. Dig Surg 6:33–38
Hölscher AH, Bollschweiler E, Petkaneschkov G, Dittler J, Becker K (1990) Effekt der proximal gastrischen Vagotomie auf die Campylobacter-pylori-Besiedelung des Magens. In: Hä-ring R et al. (Hrsg) Chirurgisches Forum für experimentelle und klinische Forschung. Springer, Berlin Heidelberg New York Tokyo
Hölscher AH, Bollschweiler E, Seebauer L, Alcock ATR, Siewert JR (1991) Experience with long-term intragastric pH monitoring as a test after proximal gastric vagotomy. In: Fuchs KH, Hamelmann H (Hrsg) Gastrointestinale Funktionsdiagnostik in der Chirurgie. Blackwell, Berlin
Holle F, Hart W (1967) Neue Wege der Chirurgie des Gastro-duodenalulcus. Med Klin 62:441–450
Johnson AG (2000) Proximal gastric vagotomy: Does it have a place in the future management of peptic ulcer? World J Surg 24:259–263
Jamieson GG (2000) Current status of indications for surgery in peptic ulcer disease. World J Surg 24:256–258
Jordan PH Jr, Thornby H (1994) Twenty years after parietal cell vagotomy or selective vagotomy antrectomy for treatment of duodenal ulcer. Ann Surg 220 (3):283–296
Katkhouda N, Waldrep DJ, Campos GM et al. (1998) An improved technique for laparoscopic highly selective vagotomy using harmonic shears. Surg Endosc 12:1051–1054
Mouiel J, Katkhouda N (1993) Laparoscopic vagotomy for chronic duodenal ulcer disease. World J Surg 17:34–39
Muller C, Martinoli S (1985) Die proximal-selektive Vagotomie in der Behandlung der gastroduodenalen Ulkuskrankheit. Springer, Berlin Heidelberg New York Tokyo
Muller C, Martinoli S, Fiedler L, Marrie A, Stalder G, Zumtobel V (1987) Lanzeiteffekte der proximal selektiven Vagotomie auf die Säuresekretion. Schweiz Rundsch Med Prax 76:132–135
Olbe L, Lind T, Cederberg C, Ekenved G (1986) Effect of omeprazole on gastric acid secretion in man. Scand J Gastroenterol [Suppl] 118:105–107
Taylor TV, Lythgoe JP, McFarland JB, Gilmore IT, Thomas PE, Ferguson GH (1990) Anterior lesser curve seromyotomy and posterior truncal vagotomy versus truncal vagotomy and pyloroplasty in the treatment of chronic duodenal ulcer. Br J Surg 77:1007–1009
Walia HS, Abd el-Karim HA (1994) Anterior lesser curve seromyotomy with posterior truncal vagotomy versus proximal gastric vagotomy: results of a prospective randomized trial 3–8 years after surgery. World J Surg 18 (5):758–763
Wetscher GJ, Then P, Profanter C, Brugger M, Hinder RA, Pointner R (1996) Laparoscopic technique of proximal selective vagotomy. Wien Klin Wochenschr 108 (9):262–266
Anonymous (1990) Proceedings of the Consensus Conference on Therapeutic Endoscopy in Bleeding Ulcers. March 6–8, 1989. Gastrointest Endosc 36:S1
Ballesteros MA, Hogan DL, Koss MA, Isenberg JI (1990) Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost. Ann Intern Med 112:334
Bombardier C, Laine L, Reicin A et al. (2000) Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343 (21):1520–1528
Brunner G, Luna P, Hartmann M, Wurst W (1996) Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med 69:225
Brunner G, Luna P, Thiesemann C (1995) Drugs for pH control in upper gastrointestinal bleeding. Aliment Pharmacol Ther 9 [Suppl l]:47–50
Caspary WF, Arnold R, Bayerdorffer E et al. (1996) Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 34:392
Chen JJ, Changchien CS, Lee CM et al. (1995) Rebleeding rate of various stigmata of recent hemorrhage in peptic ulcer bleeding with different severity. Changgeng Yi Xue Za Zhi 18:209
Cheung WL, Branicki FJ (1991) Risk factors for mortality in patients with gastric adenocarcinoma presenting with acute haemorrhage. Eur J Surg Oncol 17:270
Chow LW, Gertsch P, Poon RT, Branicki FJ (1998) Risk factors for rebleeding and death from peptic ulcer in the very elderly. Br J Surg 85:121
Chung SS, Lau JY, Sung JJ et al. (1997) Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 314:1307
Church NI, Palmer KR (2000) Injection therapy for endoscopic haemostasis. Baillieres Best Pract Res Clin Gastroenterol 14(3):427–441
Cipolletta L, Bianco MA, Marmo R et al. (2001) Endoclips versus Heater-Probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 53 (2):147–151
Cook DJ, Guyatt GH, Salena BJ, Laine LA (1992) Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 102:139
Feldman M, Burton ME (1990) Histamine-2-receptor antagonists. Standard therapy for acid-peptic diseases (2). N Engl J Med 323:1749
Forrest JA, Finlayson ND, Shearman DJ (1974) Endoscopy in gastrointestinal bleeding. Lancet 2:394
Freeman ML, Cass OW, Peine CJ, Onstad GR (1993) The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding. Gastrointest Endosc 39:359
Gabriel SE, Jaakkimainen L, Bombardier C (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787
Garcia RL, Hernandez-Diaz S (2001) The risk of upper gastrointestinal complications associated with nonsteroidal antiinflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res 3 (2):98–101
Gilbert DA, Silverstein FE, Tedesco FJ, Buenger NK, Persing J (1981) The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding. Gastrointest Endosc 27:94
Grund UE, (1997) Argon plasma koagulation. Endoscopy 29: 196–198
Grund UE, Straus T, Farin G. New hemostatic techniques: APC. Am J Gastroenterol 84:1315–1318
Howden CW (1999) Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Am J Health Syst Pharm 56:S5
Hunt RH, Cederberg C, Dent J et al. (1995) Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci 40:24S
Jensen DM (1990) Heat probe for hemostasis of bleeding peptic ulcers: technique and results of randomized controlled trials. Gastrointest Endosc 36:S42
Kubba AK, Palmer KR (1996) Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer. Br J Surg 83:461
Laine L, Peterson WL (1994) Bleeding peptic ulcer. N Engl J Med 331:717
Laine L (1990) Multipolar electrocoagulation versus injection therapy in the treatment of bleeding peptic ulcers. A prospective, randomized trial. Gastroenterology 99:1303
Laine L (1990) Therapeutic endoscopy and bleeding ulcers. Bi-polar/multipolar electrocoagulation. Gastrointest Endosc 36:S38
Langman MJ (2000) Drug treatment of non-variceal upper gastrointestinal bleeding. Baillieres Best Pract Res Clin Gastroenterol 14 (3):357–364
Lau JY, Chung SC, Leung JW, Lo KK, Yung MY, Li AK (1998) The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Endoscopy 30:513
Lau JY, Sung JJ, Lee KK et al. (2000) Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343 (5):310–316
Li Y, Sha W, Nie Y et al. (2000) Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterol Hepatol 15 (2):148–154
Libby ED (2000) Omeprazole to prevent recurrent bleeding after endoscopic treatment of ulcers. N Engl J Med 343 (5):358–359
Lin HJ, Tseng GY, Perng CL, Lee FY, Chang FY, Lee SD (1999) Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut 44:715
Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A (2000) Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 321:1103–1106
Netzer P, Inauen W (2000) Acid suppression and upper GI bleeding. Aliment Pharmacol Ther 14 (8):1104–1105
Protell RL, Gilbert DA, Silverstein FE, Jensen DM, Hulett FM, Auth DC (1981) Computer-assisted electrocoagulation: bipolar vs. monopolar in the treatment of experimental canine gastric ulcer bleeding. Gastroenterology 80:451
Protell RL, Silverstein FE, Gilbert DA, Feld AD (1981) Severe upper gastrointestinal bleeding. Part I: Causes, pathogenesis and methods of diagnosis. Clin Gastroenterol 10:17
Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D (1990) Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. JAMA 264:494
Selby NM, Kubba AK, Hawkey CJ (2000) Acid suppression in peptic ulcer haemorrhage: a „meta-analysis“. Aliment Pharmacol Ther 14 (9):1119–1126
Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J (1981a) The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointest Endosc 27:73
Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J (1981b) The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 27:80
Soehendra N, Sriram PV, Ponchon T, Chung SC (2001) Hemostatic clip in gastrointestinal bleeding. Endoscopy 33 (2): 172–180
Somerville K, Faulkner G, Langman M (1986) Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1:462
Stolte M, Seitter V, Muller H (2001) Improvement in the quality of the endoscopic/biotpic diagnosis of gastric ulcers between 1990 and 1997, an analysis of 1658 patients. Z Gastroenterol 39 (39):349–355
Sung JJ (2001) Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding. Am J Med 110:29S-32S
Wilder-Smith CH, Ernst T, Gennoni M, Zeyen B, Halter F, Mer-ki HS (1990) Tolerance to oral H2-receptor antagonists. Dig Dis Sci 35:976
Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888
Yacyshyn BR, Thomson AB (2000) Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding. Dig Dis 18 (3):117–128
Bharucha AE, Gostout CJ, Balm RK (1997) Clinical and endoscopic risk factors in the Mallory-Weiss syndrome. Am J Gastroenterol 92:805
Branichi FJ, Boey J, Fok PJ et al. (1990) Bleeding duodenal ulcer: A prospective evaluation of risk factors for rebleeding and death. Ann Surg 211:411
Brunner G, Chang J (1990) Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper upper intestinal tract: an open randomized controlled trial. Digestion 45 (4):217
Chalasani N, Cotsonis G, Wilcox CM (1996) Upper gastrointestinal bleeding in patients with chronic renal failure: Role of vascular ectasia. Am J Gastroenterol 91:2329
Cook DJ, Guyatt GH, Salena BJ et al. (1992) Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage — a meta-analysis. Gastroenterology 102:139
Crook JN, Gray LW Jr, Nance FC, Crohn 1 Jr (1972) Upper gastrointestinal bleeding. Ann Surg 175:771
DeMarkles MP, Murphy JR (1993) Acute lower gastrointestinal bleeding. Med Clin North Am 77:1085
Dronfield MW, Atkinson M, Langmann MJS (1979) Effect of different operation policies on mortality from bleeding peptic ulcer. Lancet 1:1126
Forrest AH, Finlayson NDC, Shearman DJC (1974) Endoscopy in gastrointestinal bleeding. Lancet 11:394
Foster DN, Miloszewski KJA, Losowsky MS (1979) Stigmata of recent haemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding. Br Med 1:1173
Gralnek IM, Jensen DM, Gorbein J et al. (1998) Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: An analysis of two prospective clinical trials. Am J Gastroenterol 93:2047
Green FW, Kaplan MM, Curtis LE, Levine PH (1978) Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 74:38
Griffith WJ, Neumann DA, Welsh JP (1979) The visible vessels as an indicator of uncontrolled or recurrent gastrointestinal haemorrhage. N Engl J Med 300:1411
Haaselgren G, Carlsson J, Lind T et al. (1998) Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding. Eur J Gastroenterol Hepatol 10:667
Hamlin JA, Petersen B, Keller FS et al. (1997) Angiographic evaluation and management of nonvariceal upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am 7:703
Himal HS, Watson WW, Jones CW, Miller L, MacLean LD (1974) The management of upper gastrointestinal haemorrhage: A multiparametric computer analysis. Ann Surg 179:489
Johnson WC, Widrich WC (1976) Efficacy of selective splanchi-nic arteriography and vasopressin perfusion in diagnosis and treatment of gastrointestinal hemorrhage. Am J Surg 131:481
Karanfilian RG, Yang HK, Gendler S (1996) Resection of Dieu-lafoy’s lesion by a combined endoscopic and laparoscopic approach. J Laparoendosc Surg 6:345
Khuroo MS, Yattoo GN, Javid G et al. (1997) A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 336:1054
Knauer CM (1976) Mallory-Weiss-Syndrome. Characterization of 75 Mallory-Weiss lacerations in 528 patients with upper gastrointestinal haemorrhage. Gastroenterology 71:5
Kohler B, Maier M, Benz C, Riemann JF (1997) Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci 42 (7):1370
Lau JYW, Sung JYS, Chan ACW et al. (1997) Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endoscopy 46(1):33
Lin HJ, Lo WC, Lee FY et al. (1998) A prospective randomized comparative trial showing that omeprazole prevents reblee-ding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 158:54
Macri G (1998) Eradication of Helicobacter pylory reducese the rate od duodenal ulcer rebleeding: a long term follow up study. Am J Gastroenterol 93 (6): 925
Müller C, Allgöwer M (1978) Die Vagotomie in der Behandlung des blutenden Gastroduodenalulcus. In: Häring R (Hrsg) Das komplizierte gastroduodenale Ulcus. Thieme, Stuttgart, S 39
Nielsen SP, Andrup E (1969) Mortality following surgical treatment for massive gastroduodenal hemorrhage. Acta Chir Scand [Suppl] 396:29–35
NIH Consensus Conference (1989) Therapeutic endoscopy and bleeding ulcers. JAMA 262:1269
Northfìeld TC (1971) Factors predisposing to recurrent haemorrhage after acute gastrointestinal bleeding. Br Med J 1:26
Nudel J, Guarena J, Human PJ et al. (1977) Endoscopic diagnosis of active bleeding: A prognostic sign in upper gastrointestinal hemorrhage. Gastrointest Endosc 23:237
Peterson WL, Cook DJ (1998) Antisecretory therapy for bleeding peptic ulcer. JAMA 280:877
Peterson WL, Laine L (1993) Gastrointestinal bleeding. In: Sleisenger MH, Fordtran JS (eds) Gastrointestinal disease. WB Saunders, Philadelphia
Read RC, Huebl HD, Thal AP (1970) Randomized study of massive bleeding from peptid ulceration. Ann Surg 162:561
Rockall TA (1998) Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage. Steering Group for the National Audit of Acute Upper Gastrointestinal Haemorrhage. J R Soc Med 91:518
Sacks HS, Chalmers TC, Blum AI et al. (1990) Endoscopic he-mostasis: An effective therapy for bleeding peptic ulcers. JAMA 264:494
Siewert JR, Bumm R, Hölscher AH, Dittler HJ (1989) Obere gastrointestinale Ulcusblutung. Letalitätssenkung durch früh-elektive chirurgische Therapie. DMW 114:447
Siewert JR. Castrup HJ (1982) Notfalleingriffe beim Ulcus duodeni. Chirurg 53:16
Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J (1981) The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 27:80
Stabile BE, Stamos MJ (1997) Gastrointestinal bleeding. In: Zinner MJ, Schwartz SI, Ellis H (eds) Maingot’s abdominal operations, 10th edn. Stamford, CT, Appleton &; Lange
Stabile BE (1992) Current surgical management of duodenal ulcers. Surg Clin North Am 72:335
Steffes C, Fromm D (1992) The current diagnosis and management of upper gastrointestinal bleeding. Adv Surg 25:31
Storey DW, Bown SG, Swain CP, Salmon PR, Kirkham JS, Northfìeld TC (1981) Endoscopic prediction of recurrent bleeding in peptic ulcers. N Engl J Med 305: 915
Sugawa C, Joseph AL (1992) Endoscopic interventional management of bleeding duodenal and gastric ulcers. Surg Clin North Am 72:317
Swain CP, Storey DW, Brown SG et al. (1986) Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology 90:595–608
Veldhuyzen Van Zanten SJO, Bartelsman JFWM, Schipper MEI et al. (1986) Recurrent massive hematemesis from Dieulafoy vascular malformations -a review of 101 cases. Gut 27:213
Walker TG, Waltman AC (1990) Angiographic diagnosis and therapy of upper gastrointestinal hemorrhage. In: Bennet JR, Hunt RH (eds) Therapeutic Endoscopy and Radiology of the Gut. Baltimore, Williams & Wilkins
Wara P (1985) Endoscopic prediction of major rebleeding — a prospective study of stigmata of hemorrhage in bleeding ulcer. Gastroenterology 88:1209
Wilcox CM, Alexander LN, Cotsonis G (1997) A prospective characterization of upper gastrointestinal hemorrhage presenting with hematochezia. Am J Gastroenterol 92:231
Wilcox CM, Alexander LN, Straub RF et al. (1996) A prospective endoscopic evaluation of the causes of upper GI hemorrhage in alcoholics: A focus on alcoholic gastropathy. Am J Gastroenterol 91:1343
Blomgren LGM (1997) Perforated peptic ulcer: long-term results of simple closure in the elderly. World J Surg 21:412–415
Bloom BS, Kroch E (1993) Time trends in peptic ulcer disease and in gastritis and in duodenitis: mortality, utilization and disability in the United States J Clin Gastroenterol 17:333–342
Böhm B, Ablassmaier B, Müller JM (2001) Laparoskopische Chirurgie am oberen Gastrointestinaltrakt. Chirurg 72:349–361
Boey J, Wong J, Ong GB (1982) Bacteria and septic complications in patients with perforated ulcer. Am J Surg 143: 635–639
Boey J, Choi SK, Poon A, Alagaratnam TT (1987) Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors. Ann Surg 205: 22–26
Bornman PC, Graham SM, Dunn JP (1999) Complications of peptic ulcer and their management. In: Tylor TV, Watson A, Williamson RCN (eds) Upper digestive surgery. WB Saunders, Philadelphia, pp 495–533
Chou NH, Mok KT, Chang HT, Liu SI, Tsai CC, Wang BW, Chen IS (2000) Risk factors of mortality in perforated peptic ulcer. Eur J Surg 166:149–153
Cocks JR (1992) Perforated peptic ulcer — the changing scene. Dig Dis 10:10–16
Cougard P, Barrât C, Gayral F et al. (2000) Laparoscopic treatment of perforated duodenal ulcers. Results of a retrospective multicentric study. French Society of Laparoscopic Surgery. Ann Chir 125:726–731
Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK (1989) A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med 320:970–973
Donovan AJ, Berne TV, Donovan JA (1998) Perforated duodenal ulcer: an alternative therapeutic plan. Arch Surg 133:1166–1171
Evans JP, Smith R (1997) Predicting poor outcome in perforated peptic ulcer disease. Aust N Z J Surg 67:792–795
Goodwin CS, Mendall MM, Northfield TC (1997) Helicobacter pylori infection. Lancet 349:265–269
Hermansson M, Holstein CS, Zilling T (1999) Surgical approach and prognostic factors after peptic ulcer perforation. Eur J Surg 165:566–572
Irvin TT (1989) Mortality and perforated peptic ulcer: a case for risk stratification in elderly patients. Br J Surg 76:215–218
Johnson AG (1994) Management of peptic ulcer. Br J Surg 81:161–163
Jordan PH Jr, Thornby J (1995) Perforated pyloroduodenal ulcers. Long-term results with omental patch closure and parietal cell vagotomy. Ann Surg 221:479–486
Katkhouda N, Mavor E, Mason RJ, Campos GM, Soroushyari A, Berne TV (1999) Laparoscopic repair of perforated duodenal ulcers: outcome and efficacy in 30 consecutive patients Arch Surg 134:845–848
Labenz J, Borsch G (1994) Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 89:1785–1788
Lau WY, Leung KL, Kwong KH, Davey IC, Robertson C, Dawson J J, Chung SC, Li AK (1996) A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg 224:131–138
Lee FY, Leung KL, Lai PB, Lau JW (2001) Selection of patients for laparoscopic repair of perforated peptic ulcer. Br J Surg 88:133–136
Liu TJ, Wu CC (1997) Peptic ulcer surgery: experience in Taiwan from 1982–1993. Asian J Surg 20:305–310
Marshall C, Ramaswamy P, Bergin FG, Rosenberg IL, Leaper DJ (1999) Evaluation of a protocol for the non-operative management of perforated peptic ulcer. Br J Surg 86:131–134
Metzger J, Styger S, Sieber C, von Flüe M, Vogelbach P, Harder F (2001) Prevalence of Helicobacter pylori infection in peptic ulcer perforations. Swiss Med Wkly 131: 99–103
Millat B, Fingerhut A, Borie F (2000) Surgical treatment of complicated duodenal ulcers icontrolled trials. World J Surg 24:299–306
Mouret P, Francois Y, Vignai J, Barth X, Lombard-Platet R (1990) Laparoscopic treatment of perforated peptic ulcer. Br J Surg 77:1006
Ng EK, Lam YH, Sung J J et al. (2000) Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg 231:153–158
Norris JR, Haubich WS (1961) The incidence and clinical features of penetration in peptic ulceration. JAMA 178:386
Ongolo P, Borson O, Garcia P, Gruner L, Valette PJ (1999) Acute gastroduodenal peptic ulcer perforation: contrast-enhanced and thin-section spiral CT findings in 10 patients. Abdom Imaging 24:329–332.
Palmer ED 1972) Perforation of gastroduodenal ulcer. Arch Intern Med 130:957
Reinbach DH, Cruickshank G, McColl KE (1993) Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 34:1344–1347
Roh JJ, Thompson JS, Harned RK, Hodgson PE (1983) Value of pneumoperitoneum in the diagnosis of visceral perforation. Am J Surg 146:830–833
Sillakivi T, Lang A, Tein A, Peetsalu A (2000) Evaluation of risk factors for mortality in surgically treated perforated peptic ulcer. Hepatogastroenterology 47:1765–768
Svanes C, Salvesen H, Bjerke Larssen T, Svanes K, Soreide O (1990) Trends in and value and consequences of radiologic imaging of perforated gastroduodenal ulcer. A 50-year experience. Scand J Gastroenterol 25:257–262
Svanes C, Lie RT, Svanes K, Lie SA, Soreide O (1994) Adverse effects of delayed treatment for perforated peptic ulcer. Ann Surg 220:168–175
Svanes C (2000) Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis. World J Surg 24:277–283
Tokunaga Y, Hata K, Ryo J, Kitaoka A, Tokuka A, Ohsumi K (1998) Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg 186:659–663
Tsugawa K, Koyanagi N, Hashizume M et al. (2001) The therapeutic strategies in performing emergency surgery for gastroduodenal ulcer perforation in 130 patients over 70 years of age. Hepatogastroenterology 48:156–162
Wakayama T, Ishizaki Y, Mitsusada M, Tkahashi S, Wada T, Funatsu H (1994) Risk factors influencing short-term results of gastroduodenal perforation. Surg Today 24: 681–687
Zittel TT, Jehle EC, Becker HD (2000) Surgical management of peptic ulcer disease today — indication, technique and outcome. Langenbecks Arch Surg 385:84–96
Awan A, Johnston DE, Jamal MM (1998) Gastric outlet obstruction with benign endoscopic biopsy should be further explored for malignancy. Gastrointest Endosc 48:497–500
Csendes A, Maluenda F, Braghetto I, Chutte H, Burdiles P, Diaz JC (1993) Prospective randomized study comparing three surgical techniques for the treatment of gastric outlet obstruction secondary to duodenal ulcer. Am J Surg 166:45–49
Delaney P (1978) Perioperative grading of pyloric stenosis: A long term clinical and radiological follow-up of patients with severe pyloric stenosis treated by highly selective vagotomy and dilatation of the stricture. Br J Surg 65:157–160
Hölscher AH, Siewert JR (1982) Benigne Magenausgangsstenose. In: Blum AL, Siewert JR (Hrsg) Ulcustherapie. Springer, Berlin Heidelberg New York, S 606–619
Hölscher AH, Bumm R, Siewert JR (1990) Chirurgische Therapieprinzipien bei der Rezidivprophylaxe. In: Bauernfeind P, Blum AL (Hrsg) Ulcusalmanach 1+2. Springer, Berlin Heidelberg New York Tokyo, S 87–113
Hör G, Baew-Christaw Th (1993) Nuklearmedizinische Methoden in der Gastroenterologie. In: Classen M, Siewert JR (Hrsg) Gastroenterologische diagnostik. Schattauer, Stuttgart New York, S 19–38
Hopkins RJ (1997) Current FDA-approved treatments for Helicobacter pylori and the FDA aproval process. Gastroenterol 113 [Suppll]:126–130
Khullar SK, DiSario JA (1996) Gastric outlet obstruction. Gastrointest Endosc Clin North Am 6:585–603
Lam SK, Chan PKW, Cheng PCY, Ong GB (1978) The interrelationship between bleeding, perforation, and stenosis in duodenal ulceration. Aust N Z J Surg 48:152–155
Lee J, OMoran C (1997) Who should be treated for Helicobacter pylori infection. A review of consensus conferences and guidelines. Gastroenterology 113 [Suppl 1]: 99–106
Mäkelä J, Kiviniemi H, Laitinen S (1996) Gastric outlet obstruction caused by peptic ulcer disease. Analysis of 99 patients. Hepato-Gastroenterol 43:547–552
Misiewicz JJ (1997) Management of Helicobacter pylori-related disorders. Eur J Gastroenterol Hepatol 9 [Suppl 1] : 17–21
Pelot D, Hollander D (1985) Complications of peptic ulcer disease. In: Berk JE (ed) Bockus Gastroenterology. WB Saunders, Philadelphia London Toronto, 1155–1185
Shone DN, Nikoomanesh P, Smith-Neek MM, Bender JS (1995) Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. Am J Gastroenterol 90:1769–1770
Stabile BE, Passaro E (1993) Surgery for duodenal and gastric ulcer disease. Adv Surg 26:275–306
Thomson JD, Galloway JBW (1979) Vagotomy and pyloric dilatation in chronic duodenal ulceration. Br Med J 1:1453–1455
Tokunaga Y, Hara K, Ryo J, Kitaoka A, Tokuka A, Ohsumi K (1998) Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg 186:659–663
Verhaeghe PJ, Stoppa RE, Henry XF, Myon YL (1980) Pyloric stenosis: Organic or functional? The need for an intraoperative test in peptic ulcer surgery. Int Surg 65 (4):301–303
Zittel TT, Jehle EC, Becker HD (2000) Surgical management of peptic ulcer disease today — indication, technique and outcome. Langenbecks Arch Surg 385:84–96
Alexander-Williams J, Hoare AM (1980) Postgastrektomiesyndrome. In: Siewert JR, Blum AL (Hrsg) Postoperative Syndrome. Springer, Berlin Heidelberg New York, S 113–152
Amdrup E, Andreassen JC, Bach-Nielsen P (1969) Results of partial gastrectomy for peptic ulcer. Acta Chir Scand 396:18–28
Becker HD, Lehmann L, Löhlein D, Schumpelick V, Troidl H (1982) Selektiv-proximale Vagotomie mit Ulcusexzision oder Billroth-I Resektion beim chronischen Ulcus ventricu-li. Chirurg 53: 773–777
Behrns KE, Sarr MG (1994) Diagnosis and management of gastric emptying disorders. Adv Surg 27:233–255
Bondurant FJ, Maull KI, Nelson HS, Silver SH (1987) Bile reflux gastritis. South Med J 80:161–165
Borg J, Bergström S (1969) Spätergebnisse der Resektionsbehandlung nach Billroth I und Billroth II in der Ulcuschirur-gie. Bruns Beitr Klein Chir 217:481–486
Browning GC, Cuchin KA, MacKay C (1972) Small bowel flora and bowel habits studies at intervals following vagotomy drainage. Br J Surg 59:908–910
Cay EL, Philip AE, Small WP, Neilson J, Henderson MA (1975) Patient’s assessment of the result of surgery for peptic ulcer. Lancet 1 (7897):29–31
Donahue PE, Griffith C, Richter HM (1996) A 50-year perspective upon selective gastric vagotomy. Am J Surg 172:9–12
Duthie HL (1977) Surgery for peptic ulcer. World J Surg 1:29
Duthie HL, Kwong NK (1973) Vagotomy or gastrectomy for gastric ulcer. Br Med J IV:79–81
Emas S, Fenstroem M (1985) Prospective randomized trials of selective vagotomy with pyloroplasty and selective proximal vagotomy with and without pyloroplasty in the treatment of duodenal, pyloric and prepyloric ulcers. Am J Surg 149/ 2:236–243
Emas S, Eriksson B (1992) Twelve-year follow-up of a prospective, randomized trial of selective vagotomy with pyloroplasty and selective proximal vagotomy with and without pyloroplasty for the treatment of duodenal, pyloric, and prepyloric ulcers. Am J Surg 164:4–12
Enskog L, Rydberg B, Adami HO, Enander LK, Ingvar C (1986) Clinical results 1–10 years after highly selective vagotomy in 306 patients with prepyloric and duodenal ulcer disease. Br J Surg 73:357–360
Farthing MJ (1993) Octreotide in dumping and short bowel syndromes. Digestion 54 (Suppl l):47–52
Frederiksen HJ, Johansen TS, Christiansen PM (1980) Postva-gotomy diarrhea and dumping treated with reconstruction of the pylorus. Scand J Gastroenterol 15:245–248
Haglund UH, Jansson RL, Lindhagen JGE, Lundell LR, Svartholm EG, Olbe LC (1990) Primary Roux-Y-gastrojejunosto-my versus gastroduodenostomy after antrectomy and selective vagotomy. Am J Surg 159:546–549
Hoare AM, Jones EL, Alexander-Williams J, Hawkins CF (1976) The symptomatic significance of gastritis and endoscopic hy-peraemia following gastric operations. Gut 17:396
Hölscher AH (1990) Wirkung von Octreotide beim Dumping-Syndrom. Z Gastroenterol (Suppl. 2) 28:45–59
Hölscher AH, Siewert JR (1991) Operationsindikation und chirurgische Therapie des Ulcus ventriculi. Chir Gastroenterol 4:513–521
Hollender LF, Buhr F, van Petegen RP, Alexion D, Starlinger M (1978) Hat die Resektion nach Billroth I beim Magengeschwür an Bedeutung verloren? Zentralbl Chir 103:329
Horsburgh AG, Cox RA (1965) A comparison of Polya and Billroth gastrectomy. Gastroenterology 49:381
Imhof A, Schneemann M, Schaffner A, Brandie M (2001) Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose. Swiss Med Wkly 131:81–83
Johnston D (1975) Operative mortality and postoperative morbidity of highly selective vagotomy. Br J Surg 62:160
Jordan PH, Condon RE (1970) A prospective evaluation of vagotomy, pyloroplasty, vagotomy/antrectomy for the treatment of duodenal ulcer. Ann Surg 172:547–553
Kennedy T, Green R (1978) Roux-diversion for bile reflux following gastric surgery. Br J Surg 65:323–325
Klapdor R (1982) Release of gastric inhibitory polypeptide GIP and gastrin after a meal with low glucose load in patients after Billroth-II resection, proximal duodenal pancreatectomy and jejunal bypass. Res Exp Med (Berl) 181:11
Kliems B, Paquet KJ, Lindstedt H, Mibra S (1979) Atrophic gastritis after Billroth-I gastrectomv. Endoscopy 2:127
Ladas SD, Isaacs PE, Quereshi Y, Sladen G (1983) Role of the small intestine in postvagotomy diarrhea. Gastroenterol 85:1088–1093
Langhans P (1984) Die Roux-Schlinge in der Ulcuschirurgie. In: Bunte H, Grill W, Langhans P, Siewert JR (Hrsg) Die Roux-Schlinge. Indikationen, Techniken, Resultate, edition medizin, Weinheim Deerfìeld Beach Basel, S 151–167
Lankisch PG, Siewert JR, Jennewein HM (1976) Trophischer Einfluss des Gastrins auf Magen- und Pankreassekretion beim Hund. Verh Dtsch Ges Verdauungs Stoffwechselkr 31:25
Macintyre IM, Millar A, Smith AN, Small WP (1990) Highly selective vagotomy 5–15 years on. Br J Surg 77:65–69
Madsen P, Kronborg Q, Hansen OH, Pedersen T (1976) Billroth-I gastric resection versus truncal vagotomy and pyloroplasty in the treatment of gastric ulcer. Acta Chir Scand 142:151
Malagelada JR, Philips SF, Higgins JA, Shorter RG, van Heden JA, Adson MA (1979) A prospective evaluation of alkaline reflux gastritis: Bile acid binding agents and Roux-Y-diversion. Gastroenterology 76:1192
Marcinowska EB, Talalaj MJ, Wlodarcyzk AW, Bielecki K, Zawadzki JJ, Brzozowski R (1995) Calcium/phosphate/vitamin D homeostasis and bone mass in patients after gastrectomy, vagotomy, and cholecystectomy. World J Surg 19:597–601
McGregor IL, Deveney C, Way L, Meyer JH (1976) The effect of acute hyperglycemia on meal stimulated gastric, biliary, and pancreatic secretion and serum gastrin. Gastroenterology 70:197
McKeown KD (1970) A study of peptic ulcer. Br J Surg 57:131
Mellström D, Rundgren A (1982) Long-term effects after partial gastrectomy in elderly men. Scand J Gastroenterol 17:433
Mellström D, Johansson C, Johnell O, Lindstedt G et al. (1993) Osteoporosid, metabolic aberration, and increased risk for vetrebral fractures after partial gastretomy. Calcif Tissue Int 53:370–377
Menguy R, Chey W (1980) Experiences with the treatment of alkaline reflux gastritis. Surgery 88:482–487
Mix CL (1922) Dumping stomach following gastrojejunostomy. Surg Clin N Am 2:617–623
Nielsen J, Amdrup E, Christiansen P (1973) Gastric ulcer II, Surgical treatment. Acta Chir Scand 139:460
Ovaska JT, Havia TV, Kujari HP (1986) Retrospective analysis of gastric stump carcinoma patients treated during 1946–1981. Acta Chir Scand 152:199–204
Ovaska JT, Ekfors TO, Luukkonen PE, Lempinen MJ (1988) Histological changes in the gastric stump mucosa and late clinical results after Billroth I, Billroth II and Roux-en-Y operations for peptic ulcer disease. Ann Chir Gynaecol 77: 1–5
Pääkonen M, Alhava EM, Karjaleinen B (1982) Bone mineral and intestinal calcium absorption after partial gastrectomy. Scand J Gastroenterol 17:369
Petrat H, Schröder H, Jacob M, Petrat G (1991) Results of Billroth I and Billroth II stomach resection. Zentralbl Chir 116(6):369–373
Piso P, Meyer HJ, Edris C, Jahne J (1999) Surgical therapy of gastric stump carcinoma- a retrospective analysis of 109 patients. Hepatogastroenterology 46:2643–2647
Reid DA, Duthie HL, Bransom CJ, Johnson AG (1982) Late follow-up of highly selective vagotomy with excision of the ulcer compared with Billroth I gastrectomy for treatment of benign gastric ulcer. Br J Surg 69:605–607
Rieu PMNA, Joosten HJM, Jansen JBMJ, Lamers CBHW (1994) A comparative study of gastrectomy without vagotomy with either Roux-en-Y or Billroth II anastomosis in peptic ulcer. Hepato Gastroenterol 41:294–297
Roberts KE, Randall HT, Farr HW (1954) Cardiovascular blood volume alterations resulting from intrajejunal administration of hypertonic solutions to gastrectomized patients: the relationship of these changes to the dumping syndrome. Ann Surg 140: 631–640
Schattenmann G, Ebert R, Creutzfeldt W, Siewert JR (1981) Die Bedeutung des Duodenums und Jejunums für die nahrungs-induzierte GIP-Freisetzung. Langenbecks Arch Chir 28:141
Schumpelick V, Begemann F, Peterhoff G, Flasshoof D (1979) Reflux und Refluxkrankheit im Resektionsmagen. Langenbecks Arch Chir 348: 61
Sekine T, Tsukamoto M, Sato T (1975 An evaluation of segmental gastrectomy for gastric ulcer: one to ten year follow-up. Surgery 78:508–514
Semb LS, Montclair T, Brunsgaard C (1973) Partial gastrectomy with gastro-duodenal anastomosis with or without truncal vagotomy in the treatment of peptic ulcer. Acta Hepato-gastroenterol 20:178
Shingelton WW, Floyd IK, Sonders AP (1957) Studies on postgastrectomy steatorrhea using radioactive triolean and oleic acid. Surgery 42:12
Siewert JR (1980) Chirurgische Aspekte nach Resektionen am Magen. Langenbecks Arch Chir 352:125–132
Siewert JR, Bauer H (1982) Therapeutisches Prinzip: Vagoto-mie. In: Blum AL, Siewert JR (Hrsg) Ulcus-Therapie. Springer, Berlin Heidelberg New York, S 355–397
Siewert JR, Hinder RA (1984) Der operierte Magen. In: Dem-ling L (Hrsg) Klinische Gastroenterologie. Thieme, Stuttgart, S 429–440
Siewert JR, Hölscher AH (1986) Billroth I Gastrectomy. In: Nyhus LM, Wastell C (eds) Surgery of the stomach and duodenum, 4th edn. Little Brown, Boston Toronto, pp 263–290
Taylor TV (1999) Surgical treatment of chronic duodenal ulcer. In: Taylor TV, Watson A, Williamson RCN (eds) Upper digestive surgery. WB Saunders, pp 469–494
Thomas WEG, Thompson MH, Williamson RCN (1982) The long-term outcome of Billroth-I partial gastrectomy for benign gastric ulcer. Ann Surg 195:189
Thorban S, Böttcher K, Etter M, Roder JD, Busch R, Siewert JR (2000) Prognostic factors in gastric stump carcinoma. Ann Surg 231:188–194
Toft-Nielsen M, Madsbad S, Holst JJ (1998) Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 41:1180–1186
Tovey FI, Clark CG (1980) Anemia after partial gastrectomy: A neglected curable condition. Lancet 1(8175): 956–958
Tronçon LE, Thompson DG, Ahluwalia NK, Barlow J, Heggie L (1995) Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 37:17–22
Tymper F, Rösch W, Domschke W, Demling L (1976) The functions of exocrine pancreas after exogenous and endogenous stimulation in Billroth-II patients. Acta Hepatogastro-enterol 233:444
Vecht J, Lamers CB, Masclee AA (1999) Long-term results of octreotide therapy in severe dumping syndrome. Clin Endocrinol 51:619–624
Visick AH (1946) A study of the failures after gastrectomy. Ann R Coll Engl 3:266
Walgenbach S, Junginger Th (1992) Ergebnisse der Magenresektion mit Gastrojejunostomie nach Roux wegen gastro-duodenaler Ulcera. Chirurg 63:511–515
Walters W, Lynn TE (1956) Results of 237 Billroth-I gastric resections for peptic ulcer: A 6–15 year follow-up. Ann Surg 144:464
Werner B, Leppien A, Sailer J (1975) Duodenaler Reflux und Gastritis im Billroth-I Magen. Dtsch Med Wochenschr 100:2385
Woodward ER, Hocking MP (1987) Postgastrectomy syndromes. Surg Clin N Am 67:509–520
Carter R, Brewer LA, Lindshaw DB (1980) Acute gastric volvulus: a study of 25 cases. Am J Surg 140:99–106
Hafter E (1973) Praktische Gastroenterologie. Thieme, Stuttgart
Hölscher, AH, Weiser HF, Siewert JR (1984) Hiatushernien. Internist Welt 7(1):23–27
Katkhouda N, Mavor E, Achanta K, Friedlander MH, Grant SW, Essani R, Mason RJ, Foster M, Mouiel J (2000) Laparoscopic repair of chronic intrathoracic gastric volvulus. Surgery 128:784–790
Kim SH, Lee SW, Choi WJ, Choi IS, Kim S J, Koo BH (1999) Laparoscopic resection of gastric diverticulum. J Laparoen-dosc Adv Surg Tech Al:87–91
Landreneau RJ (1997) Surgical Management of paraoesopha-geal herniation. In: Nyhus LM, Baker RJ, Fischer JE (eds) Mastery of surgery, vol 1, 3rd edn. Little Brown, Boston New York Toronto London, pp 694–707
Ottenjann R (1973) Missbildungen des Magens. In: Demling L (Hrsg) Klinische Gastroenterologie, Bd 1. Thieme, Stuttgart
Palmer ED (1951) Collective review: gastric diverticula. Int Abstr Surg 92:417–428
Wastell C, Ellis H (1971) Volvulus of the stomach: a review with a report of 8 cases. Br J Surg 58:557–562
Wieczorek RL, Seidman I, Ranson JH (1984) Congenital duplication of the stomach. Case report and review of the English literature. Am J Gastroenterol 79:597–602
<Reftitle>Literatur</Reftitle>
Ardelt-Gattinger E, Lechner H, Weger P (1998) Psychologische Aspekte der Adipositas. 19. Kongress f. angewandte Psychologie, Oktober 1998
Atkinson RL (1993) Proposed Standards for judging the success of the treatment of obesity. Am Intern Med 119:677–680
Bray GA, Gyan DM (1997) Drugs used in the-treatment of obesity. Diab Rev 5:83–103
Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996) Leptin: the tale of an obesity gene. Diabetes 45:1455–1462
Chua Ty, Mendiola RM (1995) Laparoscopic vertical banded gastroplasty: the Milwaukee experience. Obes Surg 5:77–80
Cleator IGM, Gourlay RH (1988) Ileogastrostomy for morbid obesity. Can J Surg 31:114–116
Cleator IGM, Litwin D, Phang PT, Brosseuk DT, Rae AJ (1994) Laparoscopic ileogastrostomy for morbid obesity. Obes Surg 4:358–360
Deitel M (1989) Jejunocolic and jejunoileal bypass: an historical perspective. In Deitel M (ed) Surgery for the morbidly obese patient. Lea & Febiger, Phildelphia
Drent ML, vand der Veen E A (1993) Lipase inhibition: a novel concept in the treatment of obesity. Int J Obesity 17:241–244
Eckhout GV, Willbanks O, Moore JT (1986) Vertical-ring gastroplasty for morbid obesity: five-year experience with 1463 patients. Am J Surg 152:713–716
Ellrott T, Pudel V (1998) Psychologische Aspekte der Adipositas — Prävention, Therapie, Gewichtserhaltung. In: Wechsler JG (Hrsg) Adipositas — Ursachen und Therapie, Blackwell, Berlin, S 199–214
Gibbs WW (1996) Gaining on fat. Scientific American 2:70–76
Hafner RJ, Watts, Roger J (1987) Psychological status of morbidly obese women before gastric restriction surgery. Journal of psychosomatic research 31 (5):607–612
Harris M, Harris R, Bochner S (1991) Fat, four-eyed, and female. J Appi Soc Psychol 12(6):503–516
Henriksson V (1952) Is small bowel resection justified as treatment for obesity? Nordisk Med 47:744
Holmes NJ, Brolin RE, Kaufmann JL (1994) Is morbid obesity a risk factor for postoperative venous embolism? Infect Med 11:273–278
Husemann B (1976) Experimentelle und klinische Ergebnisse nach operativer Dünndarmausschaltung. In: Reifferscheid M (Hrsg) Die chirurgische Behandlung der Fettsucht. Thieme, Stuttgart New York, S 47–72
Kark AE (1980) Jae wiring. Am J Clin Nutr 33:420–424
Kissebah A, Peiris A (1989) Biology of regional body fat distribution. Relationship to non-insulin dependent diabetes mellitus. Diabetes Metab Rev 5:83–109
Kolle K (1982) Gastric banding. OMG I7th Congress, Stockholm. Abstract 145:37
Kral JG (1978) Vagotomy as a treament for severe obesity. Lancet 1:307–308
Kral JG, Görtz L, Hermanson G, Walling GS (1993) Gastroplasty for obesity: long-term weight loss improved by vagotomy. World J Surg 17:75–79
Kremen AJ, Linner JH, Nelson CH (1954) An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 140:439
Kuczmarski RJ, Flegal KM, Campell SM, Johnson CL (1994) Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272:205–211
Kuzmak LI (1986) Silicone gastric banding: a simple and effective operation for morbid obesity. Contemp Surg 28:13–18
Long S, MacDonald KG, Swanson M, Brown B, Morris P, Dohm GL, Pories WJ (1996) The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. Gastroenterology 110:11400
Maroney D, Golub S (1992) Nurses attitudes towar obese persons and certain ethnic groups. Perceptual Motor Skills 75:387–391
Mason EE (1982) Vertical banded gastroplasty. Arch Surg 117:701–706
Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin N Amer 47:1345–1352
Mason EE, Printen KJ, Blommers TJ, Lewis JW, Scott DH (1980) Gastric bypass for obesity. Am J Clin Nutr 33:395–405
Montague CT, Farooqi S, Whitehead JP, Soos MA, Rau H, Wareham NJ et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–908
Mueller WH (1983) The genetics of human fatness. Yearbook Phys Anthropol 26:215–230
Quaade F, Vaernet K, Larsson S (1974) Stereotaxic stimulation and electrocoagulation of the lateral hypothalamus in obese humans. Acta Neurochir 30:111–117
Rand CSW, Macgregor A (1991) Successful weight loss following obesity surgery and the perceived liability of morbid obesity. Int J Obes 15:577–579
Rand C, Kuldau J (1993) Morbid obesity: a comparison between a general population and obesity surgery patients. Int J Obes 17:657–661
Schrudde J (1980) Lipexheresis in the correction of local adiposity. Int J Aesth Plast Surg 4:215–220
Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V (1979) Bilio-pancreatic bypass for obesity: II.Initial experience in man. Br J Surg 66:619–620
Sjöström LV (1992) Mortality of severely obese subjects. Am J Clin Nutr 55 [Suppl]: 516–523
Spedding M, Ouvry C et al. (1996) Neural control of dieting. Nature 23:380–488
Stunkard A, Sobal J (1995) Psychosocial consequences of obesity. In: Brownell, K, Faiburn C (Hrsg) Eating disorders and obesity. Guilford Press, London
Sylvan A, Sjolund B, Janunger KG (1995) Favourable long-term results with the end-to-side jejunoileal bypass. Obes Surg 5:357S-363S
Wadden T, Stunkard A (1987) Psychopathology and obesity. Annals of the New York Academy of Sciences 499:55–65
Wittgrove AC, Clark GW, Schubert KR (1996) Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3–30 months follow-up. Obes Surg 6:500–504
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bumm, R. et al. (2002). Gutartige Erkrankungen von Magen und Duodenum. In: Siewert, J.R., Harder, F., Rothmund, M. (eds) Praxis der Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09418-1_27
Download citation
DOI: https://doi.org/10.1007/978-3-662-09418-1_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-09419-8
Online ISBN: 978-3-662-09418-1
eBook Packages: Springer Book Archive